<DOC>
	<DOC>NCT00141063</DOC>
	<brief_summary>The purpose of this study is to compare the safety and efficacy of two doses of dexmethylphenidate to two doses of an approved, long-acting, marketed medication for ADHD (MPH) and placebo in children ages 6-12 diagnosed with ADHD.</brief_summary>
	<brief_title>Safety and Efficacy Study of Dexmethylphenidate in Children With ADHD</brief_title>
	<detailed_description />
	<mesh_term>Dexmethylphenidate Hydrochloride</mesh_term>
	<criteria>DSMIV diagnosis of ADHD Males and females aged 612 Inability of understand or follow instructions Is pregnant Diagnosis of tic disorder History of seizure disorder</criteria>
	<gender>All</gender>
	<minimum_age>6 Years</minimum_age>
	<maximum_age>12 Years</maximum_age>
	<verification_date>December 2007</verification_date>
	<keyword>ADHD, children</keyword>
</DOC>